Photothermal‐Driven Subcellular Calcium Ion Translocation and Mitochondrial Dysfunction for Augmented Tumor Therapy
Advanced Healthcare Materials · 2026-03 · 15 (12)
DOI: 10.1002/adhm.202504541 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 11.01.2026. Verfasst von Jiayi Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine Center, Beijing Chest Hospital/Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical Unive…. Hauptthemen laut MEDLINE: Mitochondria, Calcium, Photothermal Therapy, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Abstract (Originalsprache)
Photothermal therapy (PTT) shows great potential in cancer treatment due to its precise spatiotemporal control, but single‐modal PTT has limitations such as uneven heat distribution and tumor thermotolerance caused by high expression of heat shock protein 90 (HSP90) in cancer cells. Here, a photothermal‐driven nanoplatform (denoted as HCPH) was developed to regulate subcellular calcium ion translocation, induce mitochondrial dysfunction, and enhance PTT efficacy. Specifically, HCPH is based on hollow mesoporous Prussian blue nanoparticles (HMPB NPs), which are loaded with curcumin (CUR) and modified with hyaluronic acid (HA) on their surface. Under near‐infrared (NIR) laser irradiation, it exhibited excellent photothermal conversion efficiency, targeted tumor cells via CD44‐mediated endocytosis, and released CUR under acidic conditions. Notably, CUR induced endoplasmic reticulum (ER) Ca 2 ⁺ release and inhibited HSP90, while the photothermal effect of HCPH activated the TRPV1 calcium channel on the cell membrane to promote Ca 2 ⁺ influx. The dual‐pathway synergy caused cytoplasmic and mitochondrial Ca 2 ⁺ overload, leading to mitochondrial dysfunction and reduced ATP synthesis, which further inhibited HSP90 expression and formed a “PTT‐calcium disorder‐enhanced PTT” cycle. In vitro and in vivo experiments confirm that HCPH significantly improved tumor therapeutic efficacy through photothermal‐driven subcellular calcium translocation regulation and mitochondrial damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medicine Center, Beijing Chest Hospital/Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, China.
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
- Department of Medical Oncology, Beijing Chest Hospital/Beijing Tuberculosis and Thoracic Tumor Research Institute, Capital Medical University, Beijing, China.
ORCID-Profile: Hongqian Chu
Zitieren
APA
Zhang, J., Xu, W., Xu, Y., Zhu, S., Liu, W., Sun, H., Li, H., Zhang, J., Sun, Z., & Chu, H. (2026). Photothermal‐Driven Subcellular Calcium Ion Translocation and Mitochondrial Dysfunction for Augmented Tumor Therapy. Advanced Healthcare Materials, 15(12). https://doi.org/10.1002/adhm.202504541
Vancouver
Zhang J, Xu W, Xu Y, Zhu S, Liu W, Sun H, et al. Photothermal‐Driven Subcellular Calcium Ion Translocation and Mitochondrial Dysfunction for Augmented Tumor Therapy. Advanced Healthcare Materials. 2026;15(12). doi:10.1002/adhm.202504541
BibTeX
@article{Zhang2026,
author = {Zhang, Jiayi and Xu, Wenfei and Xu, Yuhui and Zhu, Shuxuan and Liu, Wenjing and Sun, Hong and Li, Hongxia and Zhang, Jingfang and Sun, Zhaogang and Chu, Hongqian},
title = {Photothermal‐Driven Subcellular Calcium Ion Translocation and Mitochondrial Dysfunction for Augmented Tumor Therapy},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {12},
doi = {10.1002/adhm.202504541}
}
EUVIMED